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Abstract
Purpose This study aimed to (1) identify subgroups of cancer
patients with distinct subtypes of depression before the start of
psychological care, (2) examine whether socio-demographic
and medical characteristics distinguished these subtypes, and
(3) examine whether people with distinct subtypes reported
differential courses of depression during psychological care.
Method This naturalistic, longitudinal study included cancer
patients who sought psychological care at specialized psycho-
oncology institutions in the Netherlands. Data were collected
before psychological care (T1) and three (T2) and nine (T3)
months thereafter. Latent class analysis was performed to
identify depression subtypes in 243 patients at T1.
Results Before starting psychological care, three depressive
subtypes were identified, differing in severity and type of
symptoms. Class 1 (47 %) with mild depression reported
mostly concentration and sleep problems and fatigue. Class
2 (41 %), with slightly higher levels of depression, reported
similar concentration and sleep problems and fatigue as class
1, and additionally depressed mood. Class 3 (12 %), with
severe depression, reported mainly a depressed mood and, to
a lesser extent but still elevated, fatigue and concentration
problems. None of socio-demographic and medical
characteristics significantly distinguished these subtypes.
These subtypes significantly predicted the course of depres-
sion over time, with class 1 reporting moderate improvements,
class 2 large improvements, and class 3 the largest
improvements.
Conclusions Results indicate the presence of three subtypes
of depression in cancer patients before starting psychological
care. Our findings suggest that psychological interventions
could be tailored to respond to the specific subtype of depres-
sion experienced by each individual.
Keywords Subtypes of depression . Cancer patients .
Psychological care . Latent class analysis
Introduction
Major depression is characterized by a range of symptoms,
with core symptoms of a depressed mood and/or loss of
interest/pleasure in normal activities, and also guilty feelings,
suicidal thoughts, concentration problems, and sleeping and
appetite problems. For a diagnosis of major depressive disor-
der (MDD), at least five of nine symptoms need to be present,
including at least one of the two core symptoms [1]. Depres-
sion is one of the most prevalent psychological problems in
cancer patients, with prevalence rates of 8 to 24.6 % [2, 3].
Depression in cancer patients may be associated with lower
quality of life [4], less adherence with cancer treatment [5],
and prolonged hospitalization [6]. Thus, detection and treat-
ment of depression in cancer patients need to be optimized.
The current broad and heterogeneous definition of depres-
sion has proven unsatisfactory, as patients may have various
combinations of symptoms. The identification of specific sub-
types of depression may increase our understanding of the
causes and optimize treatment [7–11]. Efforts have been made
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to identify distinct subtypes of depression, either using a top-
down, clinically driven approach or a bottom-up, empirically
driven approach. The top-down approach depends on a hy-
pothesized framework by pre-defining subtypes of depression
and classifying people based on descriptive clinical data [12].
For instance, depression can be differentiated based on symp-
tom presentation, time of onset characteristics, etiology, and
severity [13]. This approach has been criticized because of the
limited clinical applicability and problems in identifying and
using these subtypes [11, 13, 14]. The bottom-up, empirical
approach may help to overcome this problem and identify
meaningful heterogeneous depressive subtypes that are based
on depressive symptoms that cancer patients actually experi-
ence. The empirical approach is designed to discover structure
in the absence of a pre-existing hypothesis about the subtypes
of depression and relies on advanced statistical techniques to
identify subgroups with distinct profiles of symptoms [12].
Using an empirically driven approach, clinicians may identify
which subtype of depression each patient has and tailor psy-
chological interventions toward the specific symptoms expe-
rienced by each individual.
Specifically, latent class analysis (LCA), as an advanced
statistical technique, can be used to classify individuals with
similar profiles into heterogeneous classes based on the ob-
served scores of each individual. LCA has beenwidely used in
previous research and demonstrated its superiority in
subtyping depression in both people with MDD and general
populations [15–23]. A recent systematic review on empiri-
cally derived subtypes of depression in adults with MDD con-
cluded that there was no conclusive evidence to demonstrate
the number and type of subtypes of depression, given the great
diversity in the identified subtypes [11]. Another important
observation based on LCA was that both severity and nature
of symptoms play an important role in differentiating depres-
sive subtypes [11].
As previous studies mainly focused on general populations
and people with MDD [15–23], little is known regarding the
subtypes of depression in people with severe comorbid somat-
ic conditions such as cancer. Given the overlap between de-
pressive symptoms and cancer-related symptoms [24], it is
important to examine whether the subtypes of depression
found in other populations can be identified in cancer patients.
Specifically, depressive symptoms including sleep problems,
fatigue, loss of appetite, and weight loss can be caused by
pathophysiologic processes of cancer and/or concurrent med-
ical treatment (e.g., chemotherapy) [24, 25]. This symptom
overlap emphasizes the importance and difficulty of accurate-
ly assessing depression in cancer patients [24]. It is important
to distinguish between cognitive/affective (e.g., depressed
mood, lack of pleasure/interest) and somatic symptoms of
depression (e.g., appetite and sleep problems, fatigue) [26].
Using LCA, one study in depressed myocardial infarction
(MI) patients found three depression subtypes: a less-severe
group (60 %) reporting mainly a depressed mood with addi-
tional concentration problems and fatigue, a moderate-severe
group (23 %) reporting mainly a lack of pleasure with addi-
tional concentration problems and fatigue, and a severe group
(17 %) reporting almost all cognitive/affective and somatic
symptoms of depression [27]. So far, no studies have used
an empirically driven approach to identify subtypes of depres-
sion in the context of cancer. Thus, it remains unknown re-
garding the role of cognitive/affective and somatic symptoms
in subtyping depression in cancer patients.
In order to fill in these gaps, this study used a bottom-up,
empirically driven approach (i.e., LCA) to identify subgroups
of cancer patients with distinct subtypes of depression. We
focused on cancer patients who were receiving psychological
care at a specialized psycho-oncology institution, because
these patients would be at risk for clinically elevated depres-
sion. We only included patients with clinically elevated levels
of depression before the start of psychosocial care. As pa-
tients’ problems are assessed and diagnosed before psycho-
logical care, it seems clinically relevant to know whether pa-
tients with heterogeneous subtypes of depression can be iden-
tified at that moment. The first aim was to identify patients
with distinct subtypes of depression before psychological
care. Provided that subgroups of cancer patients with various
subtypes of depression can be identified, it is relevant to dis-
tinguish these patients. A recent study on a general population
has found that several socio-demographic and medical char-
acteristics (e.g., age, gender, education, and physical health)
could distinguish people with distinct subtypes of depression
[16]. Thus, the second aim was to examine whether these
subtypes can be distinguished by the patients’ socio-
demographic and medical characteristics. As our participants
were receiving specialized psycho-oncology care over a 9-
month period, it can be assumed that, within this context,
participants might report changes in depressive symptoms.
The changes could be due to the received psychological care
or merely reflect a natural adaptation. The third aim was to
examine whether patients with distinct subtypes of depression
reported differential changes in depression during psycholog-
ical care.
Method
Sample and procedure
Cancer patients who sought psycho-oncological care at one of
the seven specialized psycho-oncology institutions in the
Netherlands between September 2008 and March 2010 were
informed about this study. All seven psycho-oncology institu-
tions in the Netherlands were involved in this study. These
institutions aim to help cancer patients, their family, partners,
and friends to cope with cancer and offer professional care in
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the form of individual therapies, group therapies, and internet
therapies. Eligible participants were (1) diagnosed with cancer
and seeking psycho-oncological help, (2) over 18 years, and
(3) able to complete questionnaires in Dutch.
We approached 611 patients, of whom 524 agreed to
participate and gave written informed consent. The 87 de-
cliners did not differ significantly in age or gender from
those who agreed. Of these 524 patients, 401 underwent
the baseline assessment before the start of psychological
care (T1) and 123 dropped out. Of these 401 patients, 384
were included and 17 were excluded. Eight decided not to
receive psychological care, and nine did not complete the
baseline assessment. The 140 non-participants did not dif-
fer significantly from the 384 in age or gender. After
3 months, 278 (72 % of 384) completed the second assess-
ment (T2). After 9 months, 241 (63 % of 384) completed
the third assessment (T3). From T1 to T3, 143 dropped out
because of illness or other reasons. Compared with the 241
participants who completed the assessment at T3, the 143
dropouts were more likely to be male, have lower educa-
tion, have received an unfavorable prognosis, and were
less likely to undergo surgery (p<0.05). There were no
significant differences in baseline depressive symptoms
between the 241 sample and the 143 dropouts.
Of the baseline sample of 384 participants, 243 (63 % of
384) reported clinically elevated levels of depression (baseline
depressive symptoms ≥ cutoff; see BMeasures^) and were in-
cluded in the analyses. Of these 243, 157 (65 % of 243) com-
pleted the second and third follow-up assessments and were
used to examine the longitudinal course of depression be-
tween patients with distinct subtypes.
Measures
Socio-demographic and medical characteristics
A self-report questionnaire was used to collect socio-
demographic and medical characteristics (e.g., educational
level, cancer type). Educational level was classified into
three categories: low (i.e., primary/lower vocational),
middle (i.e., secondary/middle vocational), and high
(i.e., university/higher vocational). Physical symptoms
were assessed by a 10-item checklist (e.g., nausea, head-
ache) based on the physical symptoms subscale of the Rot-
terdam Symptom Checklist, which has demonstrated good
validity and reliability [28]. The 10-item checklist did not
overlap with somatic symptoms that were included in the
measure for depression. Each question can be answered on
a scale from 1 (none) to 4 (very). Total scores ranged from
10 to 40, with higher scores indicating more physical
symptoms. We found a Cronbach’s α of 0.74 in the base-
line sample of 384 participants.
Psychological care characteristics
Self-report questionnaires were used to collect psychological
care characteristics (i.e., type and duration of psychological
care) at T2 and T3. Participants were offered different
types of psychological care (i.e., individual, group, or other
therapy such as haptonomy). In the questionnaire, patients
indicated which therapies they had received. Treatments were
categorized as individual, group, individual and group (all
with/without other therapy), and other. Patients also indicated
whether their psychological care was complete or ongoing at
T2 and T3.
Depressive symptoms
The 16-item version of the Center for Epidemiological Studies
Depression Scale (CES-D) [29], which excludes the four pos-
itively formulated items, has been found to be a more valid
measure for depression in cancer patients [30]. We therefore
used this version to measure depressive symptoms. Each
question can be answered on a scale from 0 (<1 day) to 3
(5–7 days). Total scores ranged from 0 to 48, with higher
scores indicating higher depression levels. A cutoff point of
10 has previously been validated to indicate clinically elevated
levels of depressive symptoms [31]. The CES-D has shown
good reliability and validity in previous research [29].
Cronbach’s α was 0.88 in the 384 participants.
After comparing the 16 CES-D items with the Diagnostic
and Statistical Manual of Mental Disorders, Fifth Edition
(DSM-5) criteria for MDD [1], we selected 10 CES-D items
that matched the DSM-5 criteria: three items referring to
Bblues, depressed mood, and sadness^were used for assessing
depressed mood; two items referring to Beverything being an
effort and not able to get going^ were used for assessing lack
of energy/fatigue; one item were used for assessing poor ap-
petite; one item were used for assessing sleep problems; one
item referring to Bexperience life as a failure^ were used for
assessing feelings of worthlessness; one item referring to
Btrouble keeping the mind on what I was doing^ were used
for assessing concentration problems; and one item referring
to Btalking less^ were used as an indication of psychomotor
slowing [32]. Two DSM-5 criteria concerning loss of
pleasure/interest and suicidal thoughts were not covered.
The 10-item CES-D had a Cronbach’s α of 0.84 in the base-
line sample of 384 participants.
A cutoff point of eight was used for the 10-item CES-D to
select cancer patients with clinically elevated depression at
baseline. This cutoff matched the percentage of clinical cases
based on the cutoff of 10 for the 16-item CES-D: 243 partic-
ipants (63 % of the total 384) reported 10-item CES-D score
≥8, 257 participants (67 % of the total 384) reported 16-item
CES-D scores ≥10, and 98 % of the 243 were also included in
the 257. These 243 participants were included in the analysis.
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Statistical analysis
LCAwas used to identify subgroups of patients with distinct
subtypes of depression based on the 10-item CES-D in the 243
participants. All participants fully completed the 10 CES-D
items at T1.
We tested LCA models that ranged from two to five clas-
ses. Distinct latent classes represented heterogeneous sub-
groups of cancer patients with distinct subtypes of depression.
Several criteria were used to determine the model that best
represented the data. First, we inspected several statistical
criteria including the Bayesian information criterion (BIC),
the Akaike information criterion (AIC), entropy, and the
bootstrapped likelihood ratio test (BLRT). The BIC and AIC
are measures of relative fit of different models. The lower the
BIC and AIC, the better the model fits. To examine the quality
of latent class classification, entropy values were inspected. A
higher entropy (≥0.6) indicates a better quality of class sepa-
ration [33]. The BLRT tests whether a model with BK classes^
is better than a model with BK-1 classes.^ A significant BLRT
indicates that a model with K classes is better [34, 35]. Sec-
ond, we used non-statistical criteria to select the best model.
The addition of one extra class should be conceptually mean-
ingful and represent a subtype that is different from other
subtypes in the model with fewer classes [35]. The LCAwere
performed in Mplus 7.1 [36]. Based on the selected best mod-
el, each participant was given a posterior probability of being
assigned in each latent class. Each individual was classified
into one class according to their highest posterior probability.
The class membership for each individual was exported to
SPSS to represent subtypes of depression.
To examine whether socio-demographic, medical, and psy-
chological care characteristics were related to distinct sub-
types of depression, chi-squared tests and analyses of variance
(ANOVAs) were performed on each variable. To examine
whether baseline subtypes of depression predicted the longi-
tudinal course of depressive symptoms (based on the 10-item
CES-D), the interaction effect between subtypes and time was
examined with general linear modeling (GLM, p<0.05). For
patients within each subtype, separate GLMs examined the
longitudinal course of depressive symptoms. Cohen’s d was
calculated to represent the magnitude of change (small effect
d=0.3, medium effect d=0.5, large effect d>0.8) [37].
Results
Description of baseline sample
Table 1 shows the characteristics of the 243 participants. Mean
age was 50.91 years, approximately 20 % were male, almost
half were highly educated, and about 40 % were diagnosed
with breast cancer. Figure 1 presents the mean scores on the 10
CES-D items at baseline. Patients reported relatively high
scores (indicating more severe depression) on the items
Bconcentration problems,^ Beverything an effort,^ and Bcould
not get going^ and very low scores on the items Bpoor
appetite^ and Blife a failure.^
Identifying depression subtypes in the 243 participants
Table 2 presents the fit indices of the examined LCA models.
The BIC and entropy favored the three-class model, whereas
the AIC favored the four-class model. In addition, both the
three- and four-class models had significant BLRT. Thus,
from a statistical perspective, both models were acceptable.
We then compared the two models from a non-statistical per-
spective. The three-class model represented three conceptual-
ly distinct subtypes of depression, and all contained a substan-
tial number of participants (47, 41, and 12 %). For the four-
class model, one class of the three-class model (class 2) was
separated into two smaller classes, but the two smaller classes
showed similar patterns. Thus, the three-class model had a
better interpretability and was selected (Fig. 1).
Patients in class 1 (47 %) reported an overall low level of
depressive symptoms, with elevated scores on concentration
problems, sleep problems, and fatigue-related symptoms (ev-
erything an effort, could not get going). Patients in class 2
(41 %) reported higher levels of depressive symptoms than
class 1, with similar levels of concentration problems, sleep
problems, and fatigue as class 1 and additionally depressed
mood (Bfelt depressed,^ Bfelt sad^). Patients in class 3 (12 %)
reported an overall high level of depressive symptoms, with
elevated scores on depressed mood (Bfelt blue,^ felt sad, felt
depressed) as well as fatigue and concentration problems.
Predictors of depression subtypes
None of the socio-demographic, medical, and psychological
care characteristics significantly distinguished between the
three subtypes of depression (Table 1).
The course of depressive symptoms between distinct
subtypes
A significant interaction between subtypes and time showed
that the specific subtype of depression at baseline predicted
the longitudinal course of depressive symptoms (Fsubtype × time
(4, 254)=8.46, p<0.001). Patients in class 3 reported the larg-
est improvements in depressive symptoms from T1 to T3;
patients in class 2 also reported large improvements, whereas
patients in class 1 reported moderate improvements from T1
to T3 (Table 3). Specifically, patients in classes 2 and 3 report-
ed large improvements in depressive symptoms from T1 to
T2, with no significant changes between T2 and T3. In con-
trast, patients in class 1 reported mainly moderate
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Table 1 Socio-demographic, medical, and psychosocial care characteristics in the entire sample and three subtypes of depressive symptoms (n=243)
Predictor Total sample Class 1 (n=114) Class 2 (n=99) Class 3 (n=30)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) ANOVA
Age (in years) 50.91 (10.31) 50.64 (10.84) 51.28 (9.85) 50.66 (10.05) F (2, 240)=0.11n.s.
Time since diagnosis (in years) 2.84 (4.69) 2.91 (5.25) 2.59 (4.17) 3.41 (4.02) F (2, 233)=0.36n.s.
Physical symptoms at T1 7.04 (4.60) 6.71 (4.28) 6.94 (4.71) 8.75 (5.21) F (2, 239)=2.27n.s.
% % % % χ2
Gender
Man 22.6 % 21.7 % 24.2 % 20.7 % 0.26n.s.
Woman 77.4 % 78.3 % 75.8 % 79.3 %
Educational level
Low 25.1 % 22.1 % 24.2 % 40.7 % 5.08n.s.
Middle 28.1 % 26.5 % 31.6 % 22.2 %
High 46.8 % 51.3 % 44.2 % 37.0 %
Relationship
Yes 76.7 % 72.6 % 80.2 % 81.5 % 2.09n.s.
No 23.3 % 27.4 % 19.8 % 18.5 %
Cancer type
Breast cancer 41.9 % 44.7 % 38.8 % 41.4 % 16.29n.s.
Digestive system cancer 6.6 % 7.9 % 7.1 % 0.0 %
Lung cancer 5.4 % 6.1 % 5.1 % 3.4 %
Hematologic cancer 10.4 % 6.1 % 13.3 % 17.2 %
Head and neck cancer 7.5 % 5.3 % 12.2 % 0.0 %
Gynecological cancer 7.9 % 9.6 % 6.1 % 6.9 %
Multiple malignant tumors 9.5 % 8.8 % 9.2 % 13.8 %
Others 10.8 % 11.4 % 8.2 % 17.2 %
Metastases
Yes 32.1 % 31.6 % 29.6 % 42.9 % 1.78n.s.
No 67.9 % 68.4 % 70.4 % 57.1 %
Comorbid diseases
Yes 24.9 % 26.3 % 24.0 % 22.2 % 1.53n.s.
No 75.1 % 73.7 % 76.0 % 77.8 %
Perceived prognosis
Favorable 47.3 % 52.2 % 42.4 % 44.8 % 8.87n.s.
Unfavorable 26.3 % 13.0 % 11.1 % 27.6 %
Uncertain 14.0 % 22.6 % 32.3 % 20.7 %
Recurrence
Yes 14.8 % 12.2 % 16.2 % 20.7 % 1.57n.s.
No 85.2 % 87.8 % 83.8 % 79.3 %
Under medical treatment or not at T1
Yes 48.1 % 46.5 % 46.6 % 59.3 % 1.53n.s.
No 51.9 % 53.5 % 53.4 % 40.7 %
Received type of medical treatment
Operation 17.3 % 15.7 % 16.2 % 27.6 % 15.98n.s.
Chemotherapy 9.1 % 7.0 % 10.1 % 13.8 %
Radiotherapy 2.9 % 1.7 % 4.0 % 3.4 %
Operation + chemotherapy 19.8 % 20.9 % 19.2 % 17.2 %
Operation + radiotherapy 16.0 % 14.8 % 21.2 % 3.4 %
Chemotherapy + radiotherapy 5.8 % 3.5 % 8.1 % 6.9 %
Operation + chemotherapy + radiotherapy 23.0 % 28.7 % 16.2 % 24.1 %
Others 6.2 % 7.8 % 5.1 % 3.4 %
Type of psychological care (T1-T2)a
Individual 58.0 % 61.0 % 59.4 % 37.5 % 12.81n.s.
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improvements from T1 to T2 and small improvements until
T3. Additionally, the T1-T2 changes for class 3 were much
larger than the T1-T2 changes for class 2.
Discussion
With the use of a bottom-up, empirically driven approach
(LCA), this study identified subgroups of cancer patients with
distinct subtypes of depression in cancer patients receiving
psychological care at psycho-oncology institutions. Before
psychological care, three distinct subtypes of depression were
identified: class 1 (47 %), with mild depression, reported
mainly concentration problems, sleep problems, and fatigue;
class 2 (41 %) had slightly higher levels of depression than
class 1, with similar concentration and sleep problems and
fatigue as class 1 with additional depressed mood; and class
3 (12 %) reporting more severe depression mainly
characterized by depressed mood and fatigue and concentra-
tion problems. Patients’ socio-demographic, medical, and psy-
chological care characteristics (e.g., age, cancer type) did not
significantly distinguish these subtypes. However, these sub-
types at baseline predicted the courses of depression during
psychological care.
The three subtypes differed in the nature of symptoms.
Somatic problems (sleep and appetite problems) were not
found to be key symptoms differentiating subtypes, although
sleep problems were more pronounced in the less-severe sub-
types (class 1 and class 2) than in the severe subtype (class 3).
This is partly in line with a review on empirically driven
subtypes of depression, suggesting that somatic symptoms
(e.g., fatigue and sleep disturbances) are more common in
less-severely depressed patients [11]. In MI patients with
MDD, sleep and appetite problems distinguished the moder-
ately from the severely depressed individuals [27]. In our
study, as patients did not necessarily meet the diagnostic
Table 1 (continued)
Predictor Total sample Class 1 (n=114) Class 2 (n=99) Class 3 (n=30)
Group 7.0 % 5.2 % 9.4 % 6.3 %
Individual + group 16.6 % 14.3 % 20.3 % 12.5 %
Other 1.9 % 2.6 % 1.6 % 0.0 %
Missing 16.6 % 16.9 % 9.4 % 43.8 %
Psychological care finished at T2a
Yes 19.7 % 15.6 % 21.9 % 31.3 % 2.36n.s.
Type of psychological care (T2-T3)a
Individual 42.0 % 45.5 % 37.5 % 43.8 % 5.29n.s.
Group 4.5 % 6.5 % 1.6 % 6.3 %
Individual + group 19.7 % 16.9 % 25.0 % 12.5 %
Other 1.9 % 2.6 % 1.6 % 0.0 %
Missing 31.8 % 28.6 % 34.4 % 37.5 %
Psychological care finished at T3a
Yes 47.1 % 48.1 % 43.8 % 56.3 % 0.85n.s.
a These analyses were conducted in 157 patients who completed the two follow-up measurements
0.00
0.50
1.00
1.50
2.00
2.50
3.00
Class 1: 47%
Class 2: 41%
Class 3: 12%
Total sample
Fig. 1 Mean item scores of
10-item CES-D in the three latent
classes and the total sample at
baseline
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criterion of MDD, we did not include a large group with se-
verely depressed symptoms. This might explain why we
found little distinction between the subtypes regarding somat-
ic problems.
Another explanation could be the measure of somatic prob-
lems. One study in people with MDD, using a diagnostic
interview including a more specific assessment of somatic
problems, found three subtypes of depression differentiated
by somatic problems [22]. Our study included only two
CES-D items on poor appetite and sleep problems, which
might have prevented us from highlighting somatic symptoms
for differentiating subtypes of depression. Future studies in
cancer patients, with a more detailed measurement of somatic
problems, are needed to closely examine the role of somatic
problems in differentiating depression subtypes.
Our three subtypes of depression varied mainly regarding
depressed mood. This is different from findings of a previous
study in people with MDD [22]. They found three subtypes of
depression (i.e., moderate subtype, severe typical subtype, and
severe atypical subtype), of which depressed mood did not
distinguish between the three subtypes. In their study, all sub-
types reported relatively high scores on depressed mood,
which makes sense in people with MDD, as this is one of
the core symptoms of depression. Cancer patients in our
sample reported elevated levels of depressive symptoms but
did not fulfill the criteria for a diagnosis of MDD.
The three subtypes of depression also differed in their se-
verity of depressive symptoms (i.e., low, moderate, and high).
This result is in line with a systematic review, reporting that
distinct subtypes of depression (as derived by LCA) differed
in the severity of depression [11]. Empirical studies using
LCA to identify subtypes of depression reported similar find-
ings [16, 19, 22, 23]. For instance, in a study of Hybels et al. in
older adults, their three subtypes of depression differed pri-
marily by severity [16]. Unlike our study, the Hybels study did
not pre-select participants with elevated depressive symptoms,
which might explain why their largest group (59 %) reported
almost no depressive symptoms [16]. It seems to suggest that
the role of severity does not matter with the sample character-
istics (patients with clinically elevated depression or not). Al-
together, their findings, together with ours, suggest that LCA
not only classifies people based on symptoms but also on
severity.
Our three empirically driven subtypes were partly in line
with a study on clinically driven subtypes of depression in
prostate cancer patients [32]. Their study confirmed the exis-
tence of five pre-defined subtypes of depression (Bdepressed
mood,^ Bmelancholic,^ Banhedonic,^ Bsomatic,^ and
Table 2 Fit indices and class prevalence for the latent class analysis (n=243)
BIC AIC Entropy BLRT Class size n (%)
1 2 3 4 5
2-class 5983.43 5875.15 0.78 282.21*** 167 (69 %) 76 (31 %)
3-class 5907.58 5760.87 0.98 136.28*** 114 (47 %) 99 (41 %) 30 (12 %)
4-class 5932.11 5746.98 0.94 35.89* 112 (46 %) 82 (34 %) 29 (12 %) 20 (8 %)
5-class 5970.30 5746.75 0.92 22.23ns 112 (46 %) 70 (29 %) 29 (12 %) 20 (8 %) 12 (5 %)
The numbers in bold indicate the best values of each fit indices
BIC Bayesian information criterion, AIC Akaike information criterion, BLRT bootstrapped likelihood ratio test
*p<.05; ***p<.001
Table 3 Changes in the overall levels of 10-item CES-D at each class and the follow-up sample
Changes in overall levels of 10-item CES-D
T1 T2 T3 ΔT1-T2a ΔT2-T3a ΔT1-T3a
M (SD) M (SD) M (SD) F d F d F d
Class 1: n=66 11.24 (2.92) 9.59 (4.11) 8.03 (5.16) 9.98** 0.46 8.44** 0.33 15.89*** 0.77
Class 2: n=55 14.98 (2.84) 10.91 (5.81) 9.76 (5.41) 29.19*** 0.89 2.71 0.20 29.24*** 1.20
Class 3: n=12 21.11 (2.26) 10.89 (5.88) 9.11 (6.88) 27.11*** 2.29 1.43 0.28 19.76*** 2.34
Total sample: n=133 13.51 (3.95) 10.24 (5.02) 8.84 (5.42) 71.24*** 0.72 6.23* 0.27 62.83*** 0.98
a As GLM applied a listwise deletion to handle missing values, the GLM were conducted on 133 people with valid data on all CES-D items at three
measurements
**p<.01; ***p<.001
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Bcognitive^). Similarly, we found that depressed mood and
cognitive problems were important in distinguishing subtypes
of depression in cancer patients. However, we did not find
evidence supporting the other three subtypes (melancholic,
anhedonic, and somatic), which might be due to the lack of
assessment of these depression symptoms (e.g., suicidal
thoughts, diminished pleasure) in our study.
The three subtypes of depression could not be distin-
guished by socio-demographic or medical characteristics,
which differ from previous findings. In a general population,
Hybels et al. identified three subtypes of depression (Bsevere,^
Bmoderate,^ and Bno symptoms^). They found that people
with no symptoms were more likely to be younger, male,
highly educated, married, and in better physical health than
those with severe. They also found that people with moderate
were more similar to severe than to people with no symptoms
[16]. This finding may explain why we did not find significant
correlations with socio-demographic characteristics, as we did
not include patients without depressive symptoms. Addition-
ally, although statistically non-significant, patients with the
most severe depression (i.e., class 3) were more likely to have
an unfavorable prognosis, metastases, and/or cancer recur-
rence. These results seemed to suggest that the more advanced
disease might play a role in distinguishing the types of depres-
sion. The relatively small number of patients in class 3 might
have decreased the power to find significant predictors. Future
studies with a larger sample are needed to further examine this
issue.
The three subtypes of depression assessed before psycho-
logical care predicted the course of depressive symptoms
over 9 months. Although all three classes reported improve-
ments in depressive symptoms, they differed in the magni-
tude of change: class 1 reported moderate improvements,
class 2 large improvements, and class 3 the largest improve-
ments. The fact that the most severely depressed patients
(i.e., the Bsevere typical^ class) reported more improve-
ments than the other groups is in line with a previous longi-
tudinal study [22]. This study shows that the severe typical
group, reporting mainly depressed mood, was the most like-
ly to improve their symptoms. As the three subtypes also
differed in their severity of depression, an explanation may
be that it is the severity rather than the nature that explains
why people with the most severe depression had more room
for improvement. The large improvements of this group
might reflect a recovery of depression (naturally or due to
the received care) or simply statistical regression to mean.
As this is the first study examining the longitudinal courses
of depressive symptoms reported by cancer patients with
distinct subtypes of depression, future studies are needed
to replicate our findings and explore the possible reasons
for this. Additionally, due to the lack of a control group, it
remains unclear about the reasons of these improvements
(i.e., participants’ attendance of psychological care or other
reasons). Future intervention studies with a control group
are needed to further explore this issue.
This study suggests that the three subtypes of depression
differed by both the nature and severity of depressive symp-
toms. In practice, these subtypes can be identified before the
start of treatment, by systematically examining all depression-
related symptoms and the most elevated subtype of depression
for each individual. This information can be taken into ac-
count when psychologists decide on which types of treatment
to offer. For example, for patients of class 1, interventions
could be focused on cognitive (e.g., concentration problems)
and somatic problems (e.g., sleep problems, fatigue), whereas
for patients of class 3, interventions could mainly target de-
pressed mood. These findings suggest that not all cancer pa-
tients reporting elevated levels of depressive symptoms
(with many different combinations of symptoms possible)
should be offered the same type of treatment.
Several limitations should be considered when interpreting
the findings of this study. First, two DSM-5 criteria for MDD
were not assessed, which may have led to the non-
identification of other subtypes (e.g., melancholic depression).
Some studies found that anhedonia (diminished pleasure/in-
terest) could distinguish different subtypes of depression [27],
whereas others showed that depressed mood and anhedonia
cluster together [22]. Thus, future research should include all
core depressive symptoms. Second, this study used a natural-
istic design without a control group. The lack of a control
group prohibits drawing conclusions about the extent of
changes in all subtypes that were due to psychological care
or other reasons (e.g., natural adaptation). Third, the sample
size of this study was relatively small, which reduced the
power to find relevant predictors of subtypes. Fourth, our
sample consisted of cancer patients participating in psycho-
logical care and included mainly middle-aged women with
breast cancer with a high education, similar to other studies
[38]. Thus, the generalizability of our findings remains un-
clear. Specifically, given that our sample were patients seeking
help, it is likely that our sample would be at higher risk for
clinically elevated depression. This might be the reason for the
identification of the classes with moderate to high levels of
depression and the moderate- to large-sized improvements in
depressive symptoms over time. Future studies on a general
cancer population are needed to compare findings.
Notwithstanding these limitations, this study is the first to
use a bottom-up, empirically driven approach to identify sub-
types of depression in cancer patients. The advanced analytic
method provided a more detailed description regarding the
heterogeneity of depression in cancer patients. Our findings
confirm distinct subtypes of depression in cancer patients with
differential courses of depressive symptoms with psychologi-
cal care over 9 months. The identification of distinct subtypes
of depression could serve as a first step to optimize psycho-
logical care for depressed cancer patients. Future research is
1394 Support Care Cancer (2016) 24:1387–1396
needed to examine the care needs of distinct subgroups of
depressed cancer patients and their differential responses to
distinct interventions for reducing depression.
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